Ozette Technologies

Ozette Technologies is an AI-driven computational immunology company focused on unlocking the complexity of the immune system from single-cell proteomics data. Its core technology platform provides adaptive unmixing for spectral cytometry and AI-powered cell population discovery, aiming to improve data quality and accelerate biomarker identification for drug development. The company operates a dual business model, offering its 'Resolve' and 'Endpoints' software as a cloud-native service and providing full-service immune profiling through its integrated Ozette Lab. Ozette targets partnerships with pharmaceutical companies and academic institutions to advance therapeutic discovery, particularly in immuno-oncology and other immune-mediated diseases.

Cloud-native AI platform for single-cell immune data analysis. Core technologies include 'Resolve' for adaptive unmixing of spectral cytometry data, 'Discovery' for AI-driven unbiased cell population annotation, and 'Endpoints' for streamlined clinical biomarker analysis.

Ozette competes in the computational cytometry space against legacy analysis software (e.g., FlowJo, FCS Express), instrument vendors' proprietary software, and a growing ecosystem of academic and commercial machine-learning tools. Its differentiation lies in its specialized focus on adaptive unmixing and cloud-native, AI-powered discovery for high-dimensional data.